本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

44.40
+1.503.50%
盤後46.041.64+3.69%19:30 EDT
成交量:140.43萬
成交額:6,225.90萬
市值:48.22億
市盈率:-24.00
高:44.80
開:43.54
低:42.90
收:42.90
52周最高:48.40
52周最低:13.69
股本:1.09億
流通股本:8,817.09萬
量比:1.53
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
淨資產收益率:-38.03%
總資產收益率:-25.03%
市淨率:10.76
市盈率(LYR):-27.24

資料載入中...

2023/03/06

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/23

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]